Literature DB >> 2952899

Photoradiation therapy causing selective tumor kill in a rat glioma model.

A H Kaye, G Morstyn.   

Abstract

We evaluated the effect of photoradiation therapy using the photosensitizer, hematoporphyrin derivative (HpD), and the argon-pumped rhodamine dye laser tuned to 630 nm in the rat C6 glioma model. Animal models of cerebral glioma were established by implanting 10(6) C6 glioma cells in adult Wistar rats, and craniotomies were performed on normal and tumor-bearing animals. HpD in doses of up to 80 mg/kg followed by craniotomy resulted in no damage to the normal brain, and laser light at doses of up to 1200 joules/cm2 without the prior administration of HpD produced no significant damage if the craniotomy site was irrigated with normal saline to prevent a temperature rise. Photoradiation caused no brain necrosis in non-tumor bearing animals if less than 20 mg of HpD per kg and 200 joules of red light per cm2 were used. At higher doses of HpD and light, cerebral necrosis did occur. The depth of necrosis depended on the dose of both HpD and light. Treatment with 40 mg of HpD per kg and 400 joules of light per cm2 resulted in cerebral necrosis in 50% of the treated animals. The mean depth of brain necrosis was 1.3 mm. Selective kill of a cerebral glioma with sparing of the normal brain was achieved with photoradiation therapy at doses of HpD of less than 20 mg/kg and light doses of less than 200 joules/cm2. At these doses, the mean depth of tumor kill was 4.5 mm. In 2 of 10 animals, the depth of tumor destruction was more than 6 mm.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2952899     DOI: 10.1227/00006123-198703000-00009

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  10 in total

1.  Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma.

Authors:  J S Hill; S B Kahl; A H Kaye; S S Stylli; M S Koo; M F Gonzales; N J Vardaxis; C I Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

2.  Selective tumor kill of cerebral glioma by photodynamic therapy using a boronated porphyrin photosensitizer.

Authors:  J S Hill; S B Kahl; S S Stylli; Y Nakamura; M S Koo; A H Kaye
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

3.  Assessment of the experimental model of transplanted C6 glioblastoma in Wistar rats.

Authors:  F San-Galli; P Vrignaud; J Robert; J M Coindre; F Cohadon
Journal:  J Neurooncol       Date:  1989-09       Impact factor: 4.130

4.  In vivo magnetic resonance imaging of the effects of photodynamic therapy.

Authors:  N J Dodd; J V Moore; D G Poppitt; B Wood
Journal:  Br J Cancer       Date:  1989-08       Impact factor: 7.640

5.  Evaluation of a morpholinothiolporphyrin for use in photodynamic therapy.

Authors:  K W Woodburn; J S Hill; S Stylli; A H Kaye; J A Reiss; D R Phillips
Journal:  Br J Cancer       Date:  1994-09       Impact factor: 7.640

6.  Evaluation of porphyrin C analogues for photodynamic therapy of cerebral glioma.

Authors:  G Karagianis; J S Hill; S S Stylli; A H Kaye; N J Varadaxis; J A Reiss; D R Phillips
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

7.  Vascular function and the probability of skin necrosis after photodynamic therapy: an experimental study.

Authors:  K Benstead; J V Moore
Journal:  Br J Cancer       Date:  1988-05       Impact factor: 7.640

8.  Photodynamic therapy of a mouse glioma: intracranial tumours are resistant while subcutaneous tumours are sensitive.

Authors:  E A Lindsay; M C Berenbaum; R Bonnett; D G Thomas
Journal:  Br J Cancer       Date:  1991-02       Impact factor: 7.640

9.  The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy.

Authors:  L Lilge; M C Olivo; S W Schatz; J A MaGuire; M S Patterson; B C Wilson
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

10.  Chlorin Endogenous to the North Pacific Brittle Star Ophiura sarsii for Photodynamic Therapy Applications in Breast Cancer and Glioblastoma Models.

Authors:  Antonina Klimenko; Elvira E Rodina; Denis Silachev; Maria Begun; Valentina A Babenko; Anton S Benditkis; Anton S Kozlov; Alexander A Krasnovsky; Yuri S Khotimchenko; Vladimir L Katanaev
Journal:  Biomedicines       Date:  2022-01-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.